CalciMedica
Katherine Randolph has over 20 years of experience in the clinical research industry. Katherine started their career in 1997 as a CRA at Quintiles. Katherine then moved to PAREXEL International in 2008 as a Senior Project Manager. In 2012, they were promoted to Project Director at PAREXEL International. In 2014, they joined MedSource as Program Director. Most recently, in 2020, they became the Sr. Director of Clinical Operations at CalciMedica.
Katherine Randolph attended San Diego State University from 1989 to 1996.
CalciMedica
CalciMedica is a privately held, clinical-stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases.